Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Affinivax’s MAPS Vaccine Technology Reaches Clinic In Under Five Years

Feb 13 2019

• By Joseph Haas

Related Content

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs

Feb 02 2019

Pfizer: Time To Face The Lyrica Pain

Jan 29 2019

Astellas Builds Vaccine Portfolio With Affinivax Pneumococcal Candidate

Feb 28 2017

Related Companies

Affinivax, Inc.

Boston Children’s Hospital

Pfizer Inc.

Merck & Co., Inc.

Astellas Pharma, Inc.

Sanofi

GSK plc

Additional Topics

Vaccines Clinical Trials Research & Development Business Strategies Companies BioPharmaceutical Infectious Diseases

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window